Acquiring company sought to probe the reimbursement landscape and innovative contracting considerations for a gene therapy in development.

• Evaluated current payer practices to manage orphan therapies
• Interviewed senior payer and policy executives to assess unmet needs perceptions, likely utilization management, and potential financing mechanisms
• Developed case studies of analog examples
• Benchmarked target asset relative to several other competitors

• Advised client concerning value proposition, budget impact, pricing and contracting considerations and CMS engagement
• Client used input to inform imminent acquisition and market access strategy